Tag: Cirrhosis
Rifaximin Prevents Overt Hepatic Encephalopathy After TIPS
For patients with cirrhosis, rifaximin reduces odds of overt HE after transjugular intrahepatic portosystemic shunt
In Cirrhosis, Women Have Worse Frailty Scores Than Men
Frailty mediated an estimated 13 percent of the gender gap in wait-list mortality among those awaiting liver transplant
Many Infants With Hep C-Positive Moms Not Screened for HCV
Prenatal care is an important time to screen for hepatitis C, authors say
Cirrhosis Cases Rising Among Women in North America
Projected future increases in cirrhosis due to alcohol-related liver disease and nonalcoholic fatty liver disease
Patients With Cirrhosis Have Considerable Financial Burden
Lack of insurance, financial distress resulting in delayed medical care tied to lower odds of HCC surveillance
Frailty Tied to Liver Transplant Wait-List Mortality in Cirrhosis
Cirrhosis patients with ascites or hepatic encephalopathy are more likely to experience frailty
Gender Gap Seen in Accessing Alcohol Treatment With Cirrhosis
Women less likely to be treated than men; treatment visit, medication tied to improved one-year outcomes
Alcoholic Cirrhosis Linked to Increased Admissions, Costs
Compared with non-alcoholic cirrhosis, excess 30-day readmissions total 29.2 per 100 patients
Predictors of Death in Cirrhosis Include Age, BSA, MELD
Left atrial enlargement, increased heart rate and E/e', and reduced mean BP also predicted death
Serum Cystatin C Predicts Mortality With Cirrhotic Ascites
Creatinine levels not tied to mortality or type 1 hepatorenal syndrome
